Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
356.01B | 339.66B | 340.80B | 338.46B | 204.51B | Gross Profit |
100.95B | 102.26B | 100.13B | 99.81B | 70.12B | EBIT |
10.39B | 8.35B | 6.66B | 9.37B | 8.11B | EBITDA |
15.09B | 13.32B | 11.10B | 13.64B | 9.73B | Net Income Common Stockholders |
6.19B | 4.71B | 3.83B | 5.85B | 3.87B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.84B | 3.90B | 3.77B | 6.30B | 2.75B | Total Assets |
156.27B | 152.97B | 152.09B | 144.26B | 106.94B | Total Debt |
29.09B | 29.63B | 35.53B | 19.93B | 16.48B | Net Debt |
25.25B | 25.73B | 31.76B | 13.62B | 13.73B | Total Liabilities |
84.61B | 85.81B | 88.02B | 82.39B | 59.27B | Stockholders Equity |
71.67B | 67.16B | 64.08B | 61.87B | 47.67B |
Cash Flow | Free Cash Flow | |||
4.04B | 6.19B | -12.79B | 6.90B | 1.97B | Operating Cash Flow |
12.23B | 14.88B | 868.00M | 13.68B | 11.01B | Investing Cash Flow |
-7.86B | -8.81B | -13.53B | -7.05B | -9.19B | Financing Cash Flow |
-4.43B | -5.94B | 10.13B | -4.25B | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥234.09B | 19.66 | 2.73% | 11.24% | -41.84% | ||
70 Outperform | ¥124.04B | 34.45 | 1.79% | 6.03% | -41.79% | ||
66 Neutral | ¥63.28B | 12.96 | 2.82% | 0.65% | 3.63% | ||
61 Neutral | $6.69B | 11.70 | 3.06% | 3.94% | 2.59% | -21.55% | |
57 Neutral | ¥184.64B | 48.35 | 1.41% | 0.99% | -48.66% |